Possible safety issue spurs pause of COVID-19 antibody study
Independent monitors have paused enrollment in a study testing the COVID-19 antiviral drug remdesivir plus an experimental antibody therapy being
The post Possible safety issue spurs pause of COVID-19 antibody study appeared first on The Business Journal.
Source: Local New from the Business Journal | Possible safety issue spurs pause of COVID-19 antibody study